Speaking at a webinar in March 2021, Cosmo Feilding-Mellen, Co-Founder & Chief Executive of Beckley Psytech, explored the promising medical qualities of psychedelics, such as LSD and psilocybin “magic” mushrooms
Speaking at a webinar in February 2021, Dr Natalia Sannikova, Research & Development Manager and Tomas Skrinskas, Founder & CEO from Ascension Sciences presented their research of cannabinoid nanoparticles.
Latent lead from cannabis vape hardware is more common than expected and is missed by some state and national testing protocols. We present a survey of results outlining the extent of the problem and how gaps in quality and testing systems can lead to latent lead exposure. We recommend a combination of testing protocols, supplier quality management, and consumer transparency to drive the lead out of the vape hardware supply chain.
Speaking at the Analytical Cannabis Expo East Online 2020 back in October, Dr Harry Behzadi, President, CEO and Chief Technology & Innovation Officer at AccuScience Laboratories reviewed the life of a sample from sampling the cannabis plant, to custody, transfer to the laboratory, log in, preparation, and final analysis.
Speaking at the Analytical Cannabis Expo East Online 2020 back in October, Rob Dhoble, Managing Director at Havas ECS discussed a dual regulatory framework path to improve the needs of healthcare and selfcare.
Speaking at the Analytical Cannabis Expo East Online 2020 back in October, Dr Chris Beecher, CSO of IROA Technologies, presented a novel protocol for measuring cannabinoids using IROA.
Speaking in October 2020 at the Analytical Cannabis Expo East Online, Andrew Samann from OrionGMP, discussed his latest research on terpene degradation and preservation in packaging.